Kymera Therapeutics Inc (KYMR)

30.78 +2.06 (+7.17%)
Close USD Disclaimer
30.99 +0.21 (+0.68%)
Day's Range
28.17 - 31.03
52 wk Range
13.15 - 66.45
Prev. Close
28.72
Open
28.27
Volume
700,039
Average Vol.(3m)
616,794
1-Year Change
-42.09%
Market Cap
1.68B
Beta
1.49
P/E Ratio
-9.44
Type
Equity
Market
United States
ISIN
US5015751044
CUSIP
501575104
Shares Outstanding
54,590,436
Revenue
54.79M
EPS
-2.94
Dividend (Yield)
N/A (N/A%)
Next Earnings Date
Mar 09, 2023
Strong Sell Strong Buy Sell Neutral Buy
Strong Buy
How do you feel today about Kymera Therapeutics Inc?
or

Kymera News & Analysis

  • © Reuters.  sizes=

    Today's most important initiations

    By Davit Kirakosyan Raymond James reinstated coverage on Duolingo Inc (NASDAQ:DUOL) with an Outperform rating and a price target of $111 ahead of the Q3 earnings announcement on...

    • Investing.com
  •  sizes=

    Kymera earnings, Revenue miss in Q3

    Investing.com - Kymera reported on Thursday third quarter {{erl-1165399||earnings that missed analysts' forecasts and revenue that fell short of expectations. Kymera announced earnings per...

    • Investing.com
  •  sizes=

    Kymera Therapeutics Misses Q2 EPS by 8c

    Kymera Therapeutics (KYMR) reported Q2 EPS of ($0.78), $0.08 worse than the analyst estimate of ($0.70). Revenue for the quarter came in at $11.51 million versus the consensus estimate of...

    • Investing.com
  • © Reuters.  sizes=

    Kymera Therapeutics Misses Q1 EPS by 5c

    Kymera Therapeutics (KYMR) reported Q1 EPS of ($0.71), $0.05 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $9.62 million versus the consensus estimate of...

    • Investing.com

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles